Avalo Therapeutics, Inc. (AVTX)
NASDAQ·Healthcare·Biotechnology
$14.67
+7.17%
Mkt Cap $147.95M
Analyst Ratings
Buy
10
Hold
0
Sell
0
Price Target (11 analysts)
$47.14
Range $34.00 – $60.00
Implied Upside
+221.3%
Consensus $47.14 vs current $14.67
NASDAQ·Healthcare·Biotechnology
$14.67
+7.17%
Mkt Cap $147.95M
Buy
10
Hold
0
Sell
0
Price Target (11 analysts)
$47.14
Range $34.00 – $60.00
+221.3%
Consensus $47.14 vs current $14.67